Search

Displaying results 701 - 710 of 7636 in total
  1. Indication

    Cystic Fibrosis, Homozygous for the F508del CFTR Mutation

    go.drugbank.com/conditions/DBCOND0062718
    Drugs: Tezacaftor
    Synonyms: Cystic Fibrosis, Homozygous for the F508del CFTR Mutation
  2. Indication

    Short Stature Born Small for Gestational Age (SGA)

    go.drugbank.com/conditions/DBCOND0063833
    Drugs: Somapacitan
    Synonyms: Short Stature Born Small for Gestational Age (SGA)
  3. Indication

    Treatment with eculizumab for at least 6 months

    go.drugbank.com/conditions/DBCOND0145337
    Drugs: Ravulizumab
    Synonyms: Treatment with eculizumab for at least 6 months
  4. Indication

    Using estradiol as sole treatment for vulvovaginal atrophy

    go.drugbank.com/conditions/DBCOND0126001
    Drugs: Estradiol
    Synonyms: Using estradiol as sole treatment for vulvovaginal atrophy
  5. Indication

    Diet and exercise not sufficient for weight loss

    go.drugbank.com/conditions/DBCOND0133568
    Drugs: Sibutramine
    Synonyms: Diet and exercise not sufficient for weight loss
  6. Indication

    Not a candidate for curative surgery or radiation

    go.drugbank.com/conditions/DBCOND0144324
    Drugs: Cemiplimab · Cosibelimab · Dostarlimab · Lenvatinib · Nivolumab · Pembrolizumab +1 more
    Synonyms: Not a candidate for curative surgery or radiation
  7. Indication

    Not a candidate for surgery or definitive chemoradiation

    go.drugbank.com/conditions/DBCOND0144291
    Drugs: Cemiplimab · Pembrolizumab
    Synonyms: Not a candidate for surgery or definitive chemoradiation
  8. Indication

    Progression on FDA-approved therapy for gene aberrations

    go.drugbank.com/conditions/DBCOND0173126
    Drugs: Hyaluronidase (human recombinant) · Nivolumab
    Synonyms: Progression on FDA-approved therapy for gene aberrations
  9. Drug

    Dexlansoprazole

    go.drugbank.com/drugs/DB05351
    Approved

    release system: This aims to address some limitations of the older-generation PPIs, such as short plasma half-life and the need for meal-associated dosing. … Dexlansoprazole is a new-generation proton pump inhibitor (PPI) used for the management of symptoms associated with gastroesophageal reflux disease (GERD) and erosive esophagitis.

    Synonyms: LANSOPRAZOLE R-FORMCategories: Drugs for Acid Related Disorders, Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)
  10. Drug

    Dalbavancin

    go.drugbank.com/drugs/DB06219
    ApprovedInvestigational

    Modifications from these older glycoprotein classes facilitated a similar mechanism of action for dalbavancin but with increased activity and once-weekly dosing [FDA Label, F2356, A4072, A4073]. … Its use is indicated for the treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by the following gram-positive microorganisms: Staphylococcus aureus (including methicillin-susceptible

    Categories: Antibacterials for Systemic Use, Antiinfectives for Systemic UseProducts: Dalbavancin Accord 500 mg Pulver für ein Konzentrat zur Herstellung einer Infusionslösung, Dalbavancin ratiopharm 500 mg Pulver für ein Konzentrat zur Herstellung einer Infusionslösung